/Investor DB

Food and Drug Administration (FDA) — 2021 Investments

3 investments dated 2021 · listed companies and verified rows first · show all

Akonni Biosystemsakonni.cominSep 2021 · $168.1K

Akonni Biosystems is a molecular diagnostics company that develops, manufactures, and sells integrated diagnostic systems along with nucleic acid sample preparation products.

BiotechFredrick, US

Charles Daitch(Executive Officer, Director)Jon Davis(Executive Officer)inGeorge Rudy(Executive Officer)Jennifer Reynolds(Executive Officer)inDarrell Chandler(Executive Officer)

BoardTom McMahon(Director)

TRACE-ABILITY INCtraceabilityinc.comSep 2021 · $168.1K
Triple Ring Technologiestripleringtech.cominSep 2021 · $1.2M

Newark, US

Joseph Anthony Heanue(Executive Officer, Director)Brian Patrick Wilfley(a Director prior to November 23, 2015)Lester John Lloyd(a Director prior to November 23, 2015)Augustus Percival Lowell(a Director prior to November 23, 2015)Philip Henry Devlin(Executive Officer)Muslim Tyebjee(Executive Officer)in

Co-investors1315 CapitalAgility Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.